Conference
Safety and Efficacy of Low Molecular Weight Heparins for Hemodialysis in Patients with End-Stage Renal Disease: A Meta-Analysis of Randomized Trials.
Abstract
Abstract
Background: The anticoagulant management of patients with thromboembolic disease who also have end-stage renal disease is a frequently encountered and unresolved clinical problem. Low molecular weight heparins (LWMHs) are the preferred initial treatment for these disorders but are renally excreted, and generally avoided in patients with renal failure due to concerns of bioaccumulation and increased bleeding risks. …
Authors
Lim W; Cook DJ; Crowther MA
Volume
104
Publisher
American Society of Hematology
Publication Date
November 16, 2004
DOI
10.1182/blood.v104.11.1778.1778
Conference proceedings
Blood
Issue
11
ISSN
0006-4971